12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Galenea, Eisai deal

Eisai and Galenea partnered to discover and develop synaptic modulators to treat neurodegenerative diseases. The partners will use Galenea's Multiwell Automated Neuro Transmission...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >